PDCD1 and neoplasm: Cumulative results showed that increased number of mice had cleared tumors after 2 weeks of treatment in the Imprime + anti-PD1 treatment group and upon rechallenge with MC38 tumor cells in the opposite flank, only naïve controls developed palpable tumors, demonstrating that more mice in the combination group had developed memory response (Supplementary Figure 7).